Skip to content

13F-HR filed by Pivotal bioVenture Partners Investment Advisor LLC

Pivotal bioVenture Partners Investment Advisor LLC filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-13, with 11 holding rows worth $168,472,266.

Accession
0001012975-24-000471
Filed
2024-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2024

A holdings report, 11 entries on the cover page, a total value of $168,472,266 stated on the cover page (in dollars after the unit check, H1), rows summing to $168,472,266 with VALUE read as dollars as filed, 13F file number 028-20630. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VAXCYTE INC COM92243G108Stock639,539$73,080,122dollars as filed
INOZYME PHARMA INC45790W108COM4,494,851$23,508,073dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM2,120,508$19,720,725dollars as filed
OCULIS HOLDING AGH5870P102CMN1,595,918$19,565,955dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock650,695$11,009,759dollars as filed
BIOAGE LABS INC COM09077V100Stock527,647$10,975,058dollars as filed
EXSCIENTIA PLC30223G102ADS770,500$3,760,040dollars as filed
RALLYBIO CORP75120L100COM2,404,644$2,813,433dollars as filed
VIGIL NEUROSCIENCE INC92673K108COM560,595$1,906,023dollars as filed
BOLT BIOTHERAPEUTICS INC097702104COM1,891,467$1,225,671dollars as filed
IO BIOTECH INC449778109COM864,197$907,407dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-24-000471this filing2024-11-13acceptance time not in the bulk data set